NCT07517666
Genetic Information for Families After Tumor Testing Study
Enrolling by Invitation
NAAges 18+InterventionalHealth servicesAbramson Cancer Center at Penn MedicineInvestigator-initiated
~100 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:Interactive Chatbot
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Uptake of digital pre-test chatbot
Measured over 6 months from consent
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Biological parent of a child enrolled in the ORIGen cohort (AEPI24N1) who has a confirmed P/LP germline variant in a CPG.
18 years of age or older.
Speak and understand English.
Exclusion
Previous genetic testing for the familial variant.
Communication difficulties such as:
Uncorrected or uncompensated hearing and/or vision impairment. Patients who can successfully use clinical assistance devices are not excluded.
Uncorrected or uncompensated speech defects. Patients who can successfully use clinical assistance devices are not excluded.
Uncontrolled psychiatric/mental condition or severe physical, neurological or cognitive deficits rendering individual unable to understand study goals and tasks.
What this trial measures
- Uptake of digital pre-test chatbot6 months from consent
Participant completion of digital intervention as an alternative for pre-test counseling (yes/no)
- Uptake of genetic testing6 months from consent
Participant completion of genetic testing (yes/no)